EMAP-II is a tumor derived cytokine that plays a role in a wide variety of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemotactic towards neutrophils and monocytes and induces myeloperoxidase activity from neutrophils. EMAP-II clinical value is inhibiting angiogenesis of vascular beds and suppressing the growth of primary and secondary tumors with no affect to normal tissues.
- Product Reviews
Leave a review for this product and you could be eligible for a $10 Starbucks gift card.
- Product Publications
If you've used this product in a publication, let us know. Email email@example.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Name Catalog # Size CD34/HPCA1 MO18004 100 ul CD34/HPCA1 MO20026 100 ul KDR (Kinase Insert Domain Receptor) RA21018 50 ug LYVE-1 RA25047 100 ul VEGF R2 (FLK1/KDR) RA25011 100 ul VEGF R2 (FLK1/KDR) RA25011 500 ul VEGF R3 (Flt-4) MO20013 100 ul ZO1 RA34004 100 ul